Istituto Clinico Humanitas

Reports on colon cancer findings from L. Laghi and co-researchers provide new insights.(Report)
Cancer Weekly; 11/3/2009; 852 words; ...consecutive patients who underwent resection at the IRCCS Istituto Clinico Humanitas, Rozzano, Milan, Italy, from January, 1997...information, contact L. Laghi, IRCCS Ist Clinic Humanitas, Laboratories Molecular Gastroenterology, Via...

New Data from Phase III SATURN Study Showed Tarceva Improved Overall Survival When Used Immediately After Initial Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer.
Cancer Weekly; 7/28/2009; 2277 words; ...but also importantly helped patients in the study live longer," said Professor Federico Cappuzzo, M.D., Istituto Clinico Humanitas IRCCS, Milan and principal investigator of the SATURN study. "This is good news for doctors and their patients...

Data on life sciences reported by A. Doni and co-researchers.(Report)
Biotech Week; 6/24/2009; 603 words; ...International Journal of Andrology, 2009;32(3):255-64). For more information, contact A. Doni, Istituto Clinico Humanitas, Rozzano, Milan, Italy. Publisher contact information for the International Journal of Andrology is: Blackwell...

CSL Behring Announces Winners of 2009 Prof. Heimburger Awards.(Awards list)(Company overview)
Blood Weekly; 6/18/2009; 1146 words; ...derived microparticles: Evaluating their potential as prohemostatic agents Grazia Loredana Mendolicchio -- Istituto Clinico Humanitas, Rozzano (Milano), ItalyRole of Platelet Glycoprotein Iba in Modulating a-Thrombin Function Rochelle Winikoff...

MAINTENANCE TREATMENT WITH AVASTIN AND TARCEVA AIDS LUNG CANCER.
AsiaPulse News; 6/5/2009; 2404 words; ...Commenting on the two studies Professor Federico Cappuzzo, principal investigator on the SATURN study from the Istituto Clinico Humanitas IRCCS, Milan said, ATLAS and SATURN bring welcome news for patients and their physicians since extending the...